Long-Term Treatment with 300IR 5-Grass Pollen Sublingual Tablet in Grass Pollen Allergic Subjects: Safety Outcome Year after Year

被引：0
|
作者：
Golden, David B. K. [1 ]
Fahrenholz, John M. [2 ]
Renahan, Kevin E. [3 ]
Khairallah, Sandrine [4 ]
Abiteboul, Kathy [4 ]
机构：
[1] Medstar Franklin Sq Med Ctr, Baltimore, MD USA
[2] Vanderbilt Univ, Med Ctr, Nashville, TN USA
[3] Stallergenes Greer, Cambridge, MA USA
[4] Stallergenes Greer, Antony, France
来源：
JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY | 2017年 / 139卷 / 02期
关键词：
D O I：
10.1016/j.jaci.2016.12.148
中图分类号：
R392 [医学免疫学];
学科分类号：
100102 ;
摘要：
191
引用
收藏
页码：AB60 / AB60
页数：1
相关论文
共 50 条
  • [31] SAFETY OF THE 5-GRASS POLLEN SUBLINGUAL TABLET IN ADULT AND PEDIATRIC POPULATIONS WITH GRASS POLLEN-INDUCED ALLERGIC RHINOCONJUNCTIVITIS.
    Zeldin, R. K.
    Amistani, Y.
    Paolozzi, L.
    Wahn, U.
    ANNALS OF ALLERGY ASTHMA & IMMUNOLOGY, 2014, 113 (05) : A99 - A99
  • [32] Efficacy of 300IR 5-Grass Pollen Sublingual Tablet In Poly-sensitized Patients With Allergic Rhinoconjunctivitis-results of a US Study
    Zeldin, R. K.
    Paolozzi, L.
    Ambroisine, L.
    ALLERGY AND ASTHMA PROCEEDINGS, 2014, 35 (03) : 266 - 266
  • [33] Relationship between allergic disease severity and efficacy of 300IR 5-grass pollen SLIT tablets for sublingual immunotherapy
    Didier, A.
    Horak, F.
    Worm, M.
    Melac, M.
    de Beaumont, O.
    Le Gall, M.
    Montagut, A.
    Rodriguez, P.
    Malling, A.
    ALLERGY, 2011, 66 : 137 - 138
  • [34] Improvement In Quality Of Life With Administration Of A 300 IR Sublingual Tablet Of 5-grass Pollen Allergen Extract In Adults With Grass Pollen-induced Allergic Rhinoconjunctivitis
    Horak, F.
    Didier, A.
    Worm, M.
    Malling, H.
    Abiteboul, K.
    Montagut, A.
    Zeldin, R. K.
    JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY, 2012, 129 (02) : AB46 - AB46
  • [35] Safety of 5-grass pollen sublingual immunotherapy
    Monasterolo, G.
    Renato, R.
    ALLERGY, 2012, 67 : 233 - 233
  • [36] Design and objectives of ALTO: a 5-year observational study evaluating the quality of life of allergic rhino-conjunctivitis patients treated by 300IR 5-grass pollen sublingual tablet
    Didier, A.
    Bousquet, P-J
    Davila, I
    Pfaar, O.
    Robin, B.
    ALLERGY, 2014, 69 : 611 - 611
  • [37] Efficacy and safety of a 300IR five-grass pollen SLIT tablet in children and adolescents with grass pollen rhinoconjunctivitis
    Seidenberg, J.
    Agertoft, L.
    Payot, F.
    Juchet, A.
    Emeryk, A.
    M, Melac
    Le Gall, M.
    Wahn, U.
    ALLERGY, 2009, 64 : 146 - 147
  • [38] Clinical efficacy of 300IR 5-grass pollen sublingual tablet in a US study: The importance of allergen-specific serum IgE
    Cox, Linda S.
    Casale, Thomas B.
    Nayak, Anjuli S.
    Bernstein, David I.
    Creticos, Peter S.
    Ambroisine, Laurence
    Melac, Michel
    Zeldin, Robert K.
    JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY, 2012, 130 (06) : 1327 - +
  • [39] DISEASE-MODIFYING EFFECT OF 300IR 5-GRASS POLLEN SUBLINGUAL TABLETS IN THE TREATMENT OF GRASS POLLEN-INDUCED ALLERGIC RHINOCONJUNCTIVITIS IN ADULTS: ASSESSMENT OVER AN ADDITIONAL IMMUNOTHERAPY-FREE POLLEN SEASON
    Didier, A.
    Melac, M.
    Soulie, S.
    Furrer, M. P.
    Zeldin, R. K.
    RESPIROLOGY, 2012, 17 : 53 - 53
  • [40] Budget impact model of a 5-grass sublingual immunotherapy tablet for the treatment of grass pollen-induced allergic rhinitis
    Ivanova, Jasmina I.
    Kelkar, Sneha
    King, Sarah
    Birnbaum, Howard G.
    Hocker, Sue
    Phipps, Robert
    Lankow, Richard
    JOURNAL OF MEDICAL ECONOMICS, 2015, 18 (11) : 909 - 918
12345